Showing results (81-90 of 169) with videos related to
Sort By:
Pageof 17
Virus Research|August 23, 2019
Investigating the distribution of HIV-1 Tat lengths present in the Drexel Medicine CARES cohortRobert W Link, Anthony R Mele, Gregory C Antell, et al.The Journal of Infectious Diseases|September 13, 2014
Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286Allan R Tenorio, Ellen S Chan, Ronald J Bosch, et al.Retrovirology|December 17, 2013
Interactions of peptide triazole thiols with Env gp120 induce irreversible breakdown and inactivation of HIV-1 virionsArangassery Rosemary Bastian, Mark Contarino, Lauren D Bailey, et al.The Journal of Infectious Diseases|June 27, 2013
Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248Adriana Andrade, Susan L Rosenkranz, Anthony R Cillo, et al.Retrovirology|May 5, 2016
Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signaturesGregory C Antell, Will Dampier, Benjamas Aiamkitsumrit, et al.Global Health Action|August 18, 2021
Assessing eligibility for differentiated service delivery, HIV services utilization and virologic outcomes of adult HIV-infected patients in Sierra Leone: a pre-implementation analysisSulaiman Lakoh, Darlinda F Jiba, Alren O Vandy, et al.The Journal of Infectious Diseases|April 10, 2010
Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibodyJeffrey M Jacobson, Melanie A Thompson, Jacob P Lalezari, et al.International Journal of Genomics|June 17, 2017
Evidence of Divergent Amino Acid Usage in Comparative Analyses of R5- and X4-Associated HIV-1 Vpr SequencesGregory C Antell, Will Dampier, Benjamas Aiamkitsumrit, et al.Hepatology (Baltimore, Md.)|October 24, 2006
Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127Marion G Peters, Janet Andersen, Patrick Lynch, et al.Plos One|April 22, 2016
HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease SeverityMichael R Nonnemacher, Vanessa Pirrone, Rui Feng, et al.Pageof 17